The role of WCM clinical laboratories in monitoring and managing monkeypox is vital. Your engagement and adherence to these recommendations will help ensure timely identification and reporting of potential cases, aiding public health efforts.
The CDC Overview of Clade I Monkeypox Virus (MPXV) and Laboratory Recommendations are comprehensive resources that empower you with the knowledge and tools for testing protocols, continuous monitoring, and updates. Please take the time to review them, as they are invaluable in your work.
- About Mpox | CDC
- Recommendations for Mpox Specimen Testing | LOCS
- Clade I Mpox Outbreak Originating in Central Africa | CDC
- Prevention Strategies for Mpox, including Vaccinating People at Risk via Sexual Exposure, for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks | HAN
- Mpox Caused by Human-to-Human Transmission of Monkeypox Virus with Geographic Spread in the Democratic Republic of the Congo | HAN
- Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries | HAN
- Test Order – Specimen Submission | CDC
- Mpox Vaccine Recommendations | CDC
- How Mpox Spreads | CDC
- Ongoing Clade II Mpox Global Outbreak | CDC
- After Hours/Epi-on-Call Contact Lists | CSTE
Opt-in to receive updates from the CDC Laboratory Outreach Communication System.